Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

idiopathic pulmonary fibrosis

  • Effect of sildenafil add-on to antifibrotic treatment in IPF patients
    Jieun Kang, Jin Woo Song
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3763; DOI: 10.1183/13993003.congress-2021.PA3763
  • Validation of the SGRQ-I derived from SGRQ
    Thomas Skovhus Prior, Nils Hoyer, Saher Burhan Shaker, Jesper Rømhild Davidsen, Ole Hilberg, Haridarshan Patel, Elisabeth Bendstrup
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3750; DOI: 10.1183/13993003.congress-2021.PA3750
  • IPF cluster analysis highlights diagnostic delay and cardiovascular comorbidities association with outcome
    Jaume Bordas-Martínez, Ricard Gavaldà, Jessica Shull, √anesa Vicens-Zygmunt, Lurdes Planas-Cerezales, Guadalupe Bermudo-Peloche, Salud Santos, Neus Salord, Carmen Monasterio, Guillermo Suarez-Cuartin, Maria Molina-Molina
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3745; DOI: 10.1183/13993003.congress-2021.PA3745
  • Frequency of observed interstitial lung disease in a secondary care hospital in the North West of England
    Shan L Liew, Conal Hayton, Zoe Borrill, Hou Law, Georges Ng Man Kwong
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3759; DOI: 10.1183/13993003.congress-2021.PA3759
  • Real-world antifibrotic treatment persistence and clinical outcomes for patients with idiopathic pulmonary fibrosis
    Ying Qiu, Julia Zhu, Brandon Elpers, Jenny Jiang, Adesuwa Ogbomo, Rajesh Mallampati, Clare Byrne, Jackson Tang, Aryeh Fischer
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3762; DOI: 10.1183/13993003.congress-2021.PA3762
  • Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
    Masuda Norestani, M. Norestani, N. Hoyer, Z. Barrella Harboe, S.B. Shaker
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3755; DOI: 10.1183/13993003.congress-2021.PA3755
  • PFBIO EXA: A prospective cohort of respiratory hospitalization in IPF patients
    Emilia K.A. Åttingsberg, Nils Hoyer, Thomas Skovhus Prior, Elisabeth Bendstrup, Saher Shaker
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3752; DOI: 10.1183/13993003.congress-2021.PA3752
  • Carbon monoxide diffusing capacity (DLCO) in COVID-19 survivors versus idiopathic pulmonary fibrosis (IPF): the pathogenetic features
    Olha Shchudro, Ksenia Bielosludtseva, Tetyana Pertseva, Lyudmila Konopkina, Mariia Krykhtina, Lyudmyla Konopkina
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3900; DOI: 10.1183/13993003.congress-2021.PA3900
  • Pro-fibrotic phenotype of human Hermansky-Pudlak syndrome lung fibroblasts
    Bernadette Gochuico, Jennifer Wang, Lily Smith, Jasmina Abdalla, Meixing Zuo, Tesiya Franklin, Shachar Abudi, Resat Cinar, May Malicdan, Chen Han
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3613; DOI: 10.1183/13993003.congress-2021.PA3613
  • All-cause mortality in an Idiopathic Pulmonary Fibrosis (IPF) cohort: retrospective analysis with cardiac QRISK-2
    Matthew Watson, Thomas McLellan, Muhunthan Thillai
    European Respiratory Journal Sep 2021, 58 (suppl 65) PA3747; DOI: 10.1183/13993003.congress-2021.PA3747

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 121
  • Acute lung injury and critical care (82)
  • Asthma and allergy (635)
  • CF and non-CF bronchiectasis (272)
  • COPD and smoking (902)
  • Epidemiology, occupational and environmental lung disease (212)
  • Genetics (58)
  • Interstitial and orphan lung disease (485)
  • Lung biology and experimental studies (309)
  • Lung cancer (277)
  • Lung imaging (41)
  • Lung structure and function (303)
  • Mechanisms of lung disease (144)
  • Paediatric pulmonology (392)
  • Pulmonary pharmacology and therapeutics (140)
  • Pulmonary vascular disease (509)
  • Respiratory clinical practice (167)
  • Respiratory infections and tuberculosis (949)
  • Sleep medicine (263)
  • Most Read
  • Twitter
Loading

Tweets by @ERSpublications

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society